Marksans Pharma fundamental analysis
MARKSANS
182.82
1.28 (0.71%)Last updated on 19 Dec, 2025 | 15:45 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Marksans Pharma Fundamentals
P/E Ratio
23.56
P/B Ratio
3.08
Div. Yield
0.44
Sector P/E
70.53
Sector P/B
0.97
Sec. Div. Yield
0.56
Marksans Pharma Fundamentals is currently trading with a P/E Ratio of 23.56, compared to the sector average of 70.53. Its P/B Ratio stands at 3.08, while the sector’s is 0.97. In terms of returns, the stock offers a Dividend Yield of 0.44%, which is than the sector’s 0.56%.
Marksans Pharma Score Card
Price
Attractive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Marksans Pharma reflects: Price – Attractive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
